Publication
Incidence and clinical impact of absolute lymphocyte count-only progression in chronic lymphocytic leukemia.
Xiancheng Wu, Mazyar Shadman, Jenna Voutsinas, Daniel S Hippe, Timothy W Randolph, Chaitra S Ujjani, Christine Crider, Sara Keshmiri, Stephen D Smith, Ryan C Lynch, Mengyang Di, Jennifer J Huang, Paul S Martin, Brian G Till, Ajay K Gopal
- Source
- PubMed
- Retrieved
- Sep 30, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260930-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
An increase in the absolute lymphocyte count (ALC) is a component of progressive disease (PD) in chronic lymphocytic leukemia (CLL) and contributes to progression-free survival in phase 3 trials. Prior studies with chemoimmunotherapy demonstrated that PD by ALC alone (ALC PD) conferred better…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerLeukemiadictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available